AzTrials
AzTrials

Stress, PsychologicalNCT04907942

Ecological Momentary Assessment and Text Message Intervention for Stress Management

A study testing EMA + EMA and FACE Stress and EMA Alone in people with Stress, Psychological and Loneliness, run by Click Therapeutics, Inc. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Feasibility and acceptability of an Ecological Momentary Assessment (EMA) compared with an EMA plus automated text message intervention for stress management Read more about this study

Who is it for?
Ages 22 years and olderHealthy volunteers can take part
Conditions the study is for
Stress, Psychological, Loneliness, Covid19
What is being tested?
EMA + EMA and FACE Stress and EMA Alone
Could I receive a placebo?
No, everyone receives an active treatment
How many people
81 participants
Where
1 siteUnited States
Study dates
29 Oct 2020to 20 Jun 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 22 years or older
  • Must reside in an Eastern Standard Time or Central Standard Time zone
  • Able to read and write in English as demonstrated by review and completion of an Informed Consent Form
  • Own an SMS enabled smartphone
  • Scoring >5 on the 4-item Perceived Stress Scale (reflecting higher-than-average perceived stress)

Who cannot join

  • Reported cognitive impairment and/or psychiatric disorders of the psychotic spectrum
  • Enrolled in another support study
  • Currently receiving psychotherapy through telehealth
  • PHQ-9 score of 20 or greater.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Click Therapeutics

    New York, New York, 10013

Other trials in United States

About this study

Official title: Click's Ecological Momentary Assessment (EMA) and Text Message Intervention for Stress Management (FACE STRESS Study)

Feasibility and acceptability of an Ecological Momentary Assessment (EMA) compared with an EMA plus automated text message intervention for stress management

Read the detailed description

The purpose of this study is to evaluate feasibility and acceptability of an Ecological Momentary Assessment (EMA) compared with an EMA plus automated text message intervention for stress management in participants with higher-than-average perceived stress conducted in a remote setting.

Study details include:

Study Duration: 7 months Intervention Duration: 3 weeks

Being tested
EMA + EMA and FACE Stress, EMA Alone
Keywords
Stress, Anxiety, Ecological Momentary Assessment, Automated Text Message Intervention
Medical subject headings
Stress, Psychological, COVID-19, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EMA + EMA and FACE StressOther

    Also called Ecological Momentary Assessments (EMA) & FACE Stress

    1 wk of EMA (2 daily surveys per day delivered during waking hours to evaluate momentary affects) plus 2 weeks of EMA and FACE stress

  • EMA AloneOther

    Three weeks of EMA consisting of 2 daily surveys per day delivered during waking hours to evaluate ecological momentary affects.

Study groups in NCT04907942
Study groupRoleWhat they receive
1 week EMA followed by 2weeks of EMA and automated text messages of stress and copingActive comparator1 weeks of EMA (2 daily surveys per day waking hours to evaluate momentary affects) plus 2 weeks of EMA in combination of automated text messages delivered twice a day, which content follows constructs from The Transactional Model of Stress and Coping (FACE STRESS)
Receives: Other: EMA + EMA and FACE Stress
Control of EMA aloneOther3 weeks of EMA, consisting of 2 surveys per day delivered via text message and email during waking hours to prompt participants to complete the survey.
Receives: Other: EMA Alone

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants Who Completed EMA and EMA Plus Text Message Intervention or EMA Intervention Alone.

    The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+), assessed by the number of completed individuals after the initial screening, from zero as worst to all subjects (best)

    Measured: 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2021
  2. Study start29 Oct 2020
  3. Primary completion18 Dec 2020
  4. Study completion20 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
81 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04907942
Sponsor's protocol ID
DL-FACE-101
Status last verified
Apr 2025
First submitted
2 Apr 2021
Last updated
8 May 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing EMA + EMA and FACE Stress and EMA Alone in people with Stress, Psychological and Loneliness, run by Click Therapeutics, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 May 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants Who Completed EMA and EMA Plus Text Message Intervention or EMA Intervention Alone. (time frame: 3 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04907942 | AzTrials